This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lip GYH et alHypertensive heart disease: a complex syndrome or a hypertensive ‘cardiomyopathy’? Eur Heart J 2000 21 1653–1665
Unger T Neurohormonal modulation in cardiovascular disease Am Heart J 2000 139 S2–S8
Lip GYH, Li-Saw-Hee FL Does hypertension confer a hypercoagulable state? J Hypertens 1998 16 917–123
Prichard B et alHypertension and insulin resistance J Cardiovasc Pharmacol 1992 20 (Suppl 11) S77–S84
Dernellis JM et alEffects of antihypertensive therapy on left atrial function J Hum Hypertens 1996 10 789–794
Berger PB, Ryan TJ Inferior myocardial infarction. High-risk subgroups Circulation 1990 81 401–411
DiSalvo TG et alPreserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure J Am Coll Cardiol 1995 25 1143–1153
Wolfe MW Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism Am Heart J 1994 127 1371–1375
Myslinski W et alRight ventricular function in systemic hypertension J Hum Hypertens 1998 12 149–155
Olivari MT et alPulmonary haemodynamics and right ventricular function in hypertension Circulation 1978 57 1185–1190
Dornellis JM Right atrial function in hypertensivepatients: effects of antihypertensive therapy J Hum Hypertens 2001 15 463–470
Kannal WB et alEpidemiologic features of chronic atrial fibrillation NEJM 1982 306 1018–1022
Du X et alStroke risk from multiple risk factors combined with hypertension: a primary care based case-control study in a defined population of north-west England Ann Epidemiol 2000 10 380–388
Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomised controlled trials Arch Intern Med 1994 154 1449–1457
DeDivitiis M et alRight atrial appendage thrombosis in atrial fibrillation: its frequency and its clinical predictors Am J Cardiol 1999 84 1023–1028
Roman MJ et alDifferential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy Am J Hypertens 1998 11 387–396
Aepfelbacher FC et alDisparate effects of ACE inhibitors and calcium antagonists on left ventricular structure and function in essential hypertension J Hum Hypertens 1997 11 321–325
Bertoli L et alEffects of captopril on haemodynamics and blood gases in chronic obstructive lung disease with pulmonary hypertension Respiration 1986 49 251–256
Sajkov D et alA comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD Chest 1997 111 1622–1630
Yoshimura K et alEffects of angiotensin converting enzyme inhibitor and calcium channel blocker on normoxic and hypoxic pulmonary vascular tone in unanaesthetised sheep Jpn Circ J 1987 51 1138–1146
Acknowledgements
We acknowledge the support of the City Hospital NHS Trust Research & Development Programme.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chung, N., Lip, G. Right atrial function in hypertension. J Hum Hypertens 15, 439–441 (2001). https://doi.org/10.1038/sj.jhh.1001164
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001164